SPONSOR
Institut Claudius Regaud
Total Trials
5
Recruiting
5
Phases
Phase 1, Phase 2, Phase 3
Conditions studied: MelanomaImmune DefectTumor SkinNeuroblastomaUrothelial Bladder CancerSolid CancersCervical CarcinomaAdenocarcinomaAdenosquamous Carcinoma
NCT05867004
Recruiting
Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
Melanoma
NCT03966651 Phase 1
Recruiting
A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.
Neuroblastoma
NCT04428554 Phase 2
Recruiting
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy
Urothelial Bladder Cancer
NCT03514368
Recruiting
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy
Solid Cancers
NCT05581121 Phase 3
Recruiting
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Cervical Carcinoma